New imaging technique could reveal how brain tumors hide from the immune system

NCT ID NCT05267509

Ongoing Knowledge-focused Sponsor: Istituto Oncologico Veneto IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how aggressive brain tumors (gliomas) suppress the immune system. Researchers will use special MRI and PET scans to track immune cells and iron levels in the tumor. The goal is to find better ways to measure immune suppression, which could help develop new treatments. The study involves 31 adults with malignant glioma.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help identify new ways to measure immune suppression in brain tumors, potentially guiding future treatments.
What could go wrong: This is a small, early-stage observational study (31 participants) that does not test a treatment. It may not lead to direct patient benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA, MALIGNANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioma malignant glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLIOMA, MALIGNANT

Contacts and locations

Locations

University Hospital

Florence, Italy
University Hospital

Padova, 325128, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.